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Abstract 
Key positive outcomes for hospice patients include the prevention and alleviation 
of physical and psychological distress, maintenance of physical and mental functioning 
and all aspects of quality of life. This research used secondary analysis of previously 
gathered data to answer new research questions with alternative strategies to examine 
relationships not previously analyzed.  The researchers collected data from 717 cancer 
patients who had been admitted to one of two private hospices. The aim of their 
experimental intervention was to define the effectiveness of using standardized 
assessment tools to provide systematic feedback to hospice staff about hospice patients 
and their caregivers. The aim of this secondary analysis was to assess the mediating 
effect of constipation distress on the relationship between constipation intensity and the 
hospice patients’ QOL. Variables included in the analysis were:  Quality of Life, 
Constipation Distress, Sociodemographic Characteristics (Age, gender, marital status, 
race/ culture, education, and socioeconomic status), Clinical Characteristics (Type of 
cancer, Co-morbidities, Functional/mental Health status), and Constipation Intensity.  
The data analyzed using descriptive statistics, including the frequency, 
percentage, means and standard deviation for quality of life. A relationship between 
quality of life and sociodemographic variables and between quality of life and clinical 
characteristics were evaluated with Pearson correlation coefficients. An exploratory 
mediation analysis was used to assess the mediation effect of the constipation distress. 
 vi 
 
Results showed that age, ethnicity, constipation severity and functional status 
were predictors of QOL (P<0.0), and the bootstrapping showed that constipation distress 
has a mediation effect on the relationship between constipation severity and quality of 
life. The symptom intensity and distress as well as the relationship between constipation 
and quality of life need to be seen in a holistic approach to achieve the best symptom 
management for cancer patients. 
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Chapter One: Introduction 
Globally, cancer is recognized as a major public health concern. According to the 
American Cancer Society, more than 1.5 million  new cancer cases and 570,000 cancer-
related deaths occur annually in the United States (Jemal, et al., 2008).  Constipation is a 
common problem for cancer patients, and is a frequent adverse effect of cancer-
associated pain treatment with opioid analgesics (Mercadante, Ferrera, & Casuccio, 
2011). Constipation increases the burden on cancer patients by affecting their overall 
quality of life (QOL) and increasing their level of pain and distress. As a result of severe 
constipation, patients complain of gastrointestinal tract problems such as vomiting and 
hemorrhoids which lead to increased emergency room visits and hospitalizations. 
Constipation burden does not affect the patient alone ; it also increases the burden on the 
families as well as health care system costs (Librach, et al., 2010). 
More than 60% of patients with constipation are inadequately treated because of 
the under-estimation of constipation intensity and ineffective treatment. In some cases,  
no treatment is given at all (Laugsand, Jakobsen, Kaasa, & Klepstad, 2010). It is 
estimated that more than 40% of cancer patients with opioid-related constipation may not 
be receiving laxatives as prophylaxis, and their constipation may not be managed 
properly. These patients report discomfort, distress and pain (Wee, et al., 2010). Patients 
with severe constipation have a lower QOL  and  higher treatment costs (Hjalte, 
Berggren, Bergendahl, & Hjortsberg, 2010).  
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Constipation is a serious problem for cancer patients near the end of life, but the 
literature does not address the distress caused by constipation and the effect of this 
distress on the QOL of patients with advanced cancer. Symptom distress is a component 
of the broader, multidimensional construct of the symptom experience (Goodell & Nail, 
2005). Symptom distress is the degree of discomfort associated with a symptom as 
experienced by the patient, and it reflects the patient's interpretation of a symptom 
(Molassiotis, Wengstrom, & Kearney, 2010).  Symptom distress is defined as "the degree 
of perceived discomfort experienced in relation to a symptom" (Cimprich, 1999).   
The patient’s experience of symptoms consists of physiological and psychological 
dimensions, this is why patients develop a response to their symptoms based on what 
meaning they attribute to them. One of the main dimensions of the symptom experience 
is distress. Higher levels of symptoms severity have been predictive of higher levels of 
symptom distress and poor quality of life (Bevans, Mitchell, & Marden, 2008). 
Patients' symptom experiences are known to be their perception and response to 
symptom occurrence and symptom distress. Symptom occurrence measures the 
prevalence of the symptom. Symptom distress is the amount of physical and/or mental 
upset that patient’s experience (Rhodes, McDaniel, Matthews 1998). QOL is a 
multifaceted concept with a variety of domains. Depending on the investigators, these 
domains might include psycho-physiological, functional, and social/spiritual well-being 
(Aaronson et al., 1993, Cohen et al., 1997, Ferrans, 1990; McMillan et al., 2006). 
 Palliative care and hospices have developed rapidly since the late 1960s. The 
pioneering work of Dr. Cicely Saunders was instrumental in drawing attention to the end-
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of-life care needs of patients with advanced malignant disease. Palliative care began to be 
defined in the 1970s and came to be synonymous with the physical, social, psychological, 
and spiritual support of patients and significant others with life-limiting illness, delivered 
by a multidisciplinary team. Palliative care services have developed in many settings and 
have often been closely related to oncology. The global need for this type of care remains 
much greater than what is currently available. However, there are encouraging signs of 
recognition by policymakers and influential bodies, and interest in palliative care has 
never been greater (Clark, 2007).  
Hospices provide palliative care with the goal of improving patient QOL. A 
critical component in improving QOL is aggressive management of physical symptoms. 
Physical symptoms most commonly experienced by cancer patients are reported to 
include fatigue, dyspnea, pain and constipation (Donnelly & Walsh, 1995; Weitzner, 
Moody & McMillan, 1997). Constipation causes some degree of symptom distress and 
has a negative effect on the patient’s overall QOL. In a study of 393 patients with cancer, 
patients ranked constipation control as sixth in importance out of 25 items related to 
overall QOL (Stark, Tofthagen, Visovsky, & McMillan, 2012 ). Uncontrolled symptoms 
clearly have a negative impact on all aspects of QOL, including emotional and spiritual 
well-being, social relationships, and functional ability (Kurtz, Kurtz, Given, & Given, 
1993; McMillan & Weitzner, 1998). Most clinicians and researchers agree that 
improvement in the patient's QOL is the ultimate goal in care of cancer patients near the 
end of life, and this is consistent with the approach of the World Health Organization 
(WHO). The expected outcome of palliative and hospice care is to control patients’ 
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symptoms to ensure a high level of QOL in all it is dimensions (Berger, Shuster, & Von 
Roenn, 2006). 
 Palliative care is a young discipline for research, though expert opinions have 
been helpful. The lack of extended research programs addressing basic biological 
mechanisms of patients with advanced disease and short life expectancy nationally has 
created an increasingly strong call for research in palliative care. Obstacles and 
challenges include ethical concerns about collecting data from these very ill patients, 
establishment of a research agenda, the number of experienced researchers available at 
the university level, and funding for palliative care research. Committed individuals have 
conducted important research, and if their efforts are combined with professional 
leadership, funding might be secured to establish the programs necessary to address 
palliative care research (Kaasa & Dale, 2005). 
Statement of the Problem 
Constipation is among the more common symptoms that require recognition and 
treatment, and one that is known to be negatively correlated with quality of life 
(McMillan & Weitzner, 1998). The literature addressing whether there is an effect of 
constipation distress as a predictor of hospice patient’s quality of life is very limited, 
despite it being a significant problem for cancer patients near the end of life. Crucial 
positive outcomes for hospice patients include prevention and alleviation of physical and 
psychological distress, maintenance of physical and mental functioning and support for 
all aspects of QOL. Nurses encounter patients with constipation in a variety of practice 
settings; and have a pivotal role in identifying patients at risk and implementing 
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evidence-based interventions (Woolery et al 2008). Nurses are instrumental in control of 
constipation, and enhancing QOL in patients with advanced cancer (Fredericks, Hollis, & 
Stricker, 2010). The purpose of the proposed  study was to determine, using an existing 
data set, predictors of QOL and to evaluate the mediating effect of constipation distress in 
patients who receive homecare from a large nonprofit hospice.  
Research Questions  
This study addressed the following questions: 
1. Do socio-demographic variables (age, gender, marital status, race/culture, 
education, and socioeconomic status), clinical characteristics (type of cancer, 
physical and mental status) and constipation intensity predict quality of life 
in hospice patients with cancer? 
2.  To what extent does constipation distress serve as a mediator in the 
relationship between constipation intensity and overall quality of life in 
hospice patients with cancer?  
Conceptual Framework 
Constipation causes symptom distress and has a negative effect on the patient’s 
overall QOL. This framework posits that there is a direct path and effect between 
constipation intensity and the patient’s overall QOL with and without the distress being a 
mediator in the relationship.  In the past, the social sciences considered the terms 
mediator and moderator to be synonymous (Baron & Kenny, 1986). Contemporary 
thought considers mediation as a variable that accounts for all or part of the relationship 
 6 
 
between a predictor variable and outcome. A mediator also can be explained as a 
transmitter of the effect of an independent variable (IV) on a dependent variable (DV). So 
the IV affects the DV because the IV affects the mediator, and the mediator in sequence 
affects the DV. (Preacher, Rucker, & Hayes, 2007). Statistical significance of the 
mediated effect can be calculated by dividing the estimate by its standard error and 
comparing the result with the standard normal distribution. For non-normality of data, 
both confidence limits for mediated effects and resampling methods could be used 
(MacKinnon & Fairchild, 2009). 
The aim of end of life care is to enhance QOL for patients; QOL is valued as a 
primary outcome. Several domains contribute to an individual’s overall QOL. These 
include psychophysiological, functional, and social/spiritual well-being (McMillan & 
Weitzner, 1998). A conceptual framework for evaluating QOL of cancer patients is very 
important because it structures assessment of all domains and predictors and can quantify 
an individual patient's QOL through sociodemographic and clinical characteristics. In 
addition, it may determine relationships between symptom distress caused by 
constipation and cancer patient's quality of life.   
Definition of Variables  
 For the purpose of this study the following terms are defined: 
1.    Quality of Life (QOL) is a multifaceted concept with a variety of domains. 
For the purpose of this research, these domains include psychophysiological, functional, 
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and social /spiritual well-being (Aaronson et al., 1993, Cohen et al., 1997, Ferrans, 1990; 
McMillan et al., 2006).  
 
Figure 1 Conceptual framework 
 
2.    Patients' symptom experiences are known to be their perception and response 
to symptom occurrence and symptom distress.  
3.    Symptom occurrence is the frequency and severity of the symptom.  
 8 
 
4.    Symptom distress is the amount of physical and/or mental upset that may 
experience by patients (Rhodes, McDaniel, Matthews 1998). Symptom distress is a 
component of the broader, multidimensional construct of the symptom experience 
(Goodell& Nail, 2005). Symptom distress is known as the degree of discomfort 
associated with a symptom as experienced by the patient, and it reflects the patient's 
interpretation of a symptom (Molassiotis, et al., 2010).  Symptom distress also is defined 
as "the degree of perceived discomfort experienced in relation to a symptom" (Cimprich, 
1999). 
Significance of the Study 
There is a paucity of extant  literature addressing the effect of constipation as a 
predictor on hospice patient’s quality of life However, constipation is a significant 
problem for cancer patients near the end of life (Garrison, Overcash, & McMillan, 2011). 
Expert opinion has been always useful for the palliative care discipline because so few 
studies have been conducted in this population; this highlighted the importance of having 
more research on the national level (Kaasa & Dale, 2005). 
Results of this secondary analysis may provide nurses with more knowledge 
about the impact of symptom distress in cancer patients, and its relationship with cancer 
patient's quality of life.  Availability of skillful supportive care is a right for cancer 
patients near the end of life and their families. Results of this study may influence 
curricular changes. In the field of education, both educators and professionals should start 
to change the curriculum for all university levels; graduate and undergraduate, and for 
continuing education departments at hospitals and hospices to insure that health care 
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provider's skills and knowledge are based on evidence. Nurses and other health care 
providers should be committed to improving care for their patients and alleviating 
suffering for cancer patients near the end of life by managing their symptoms.  
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Chapter Two: Review of Literature 
The literature review is divided into four sections: First, predictors of QOL are 
addressed; second, symptom distress and QOL in cancer patients near the end of life are 
discussed. The third section of the literature review addresses constipation and cancer, 
and finally the relationship between constipation and QOL are presented. 
Predictors of Quality of Life in Cancer Patients Near the End of Life 
Previous research indicates that a number of variables may affect QOL in persons 
with cancer. Age has often been found to be a significant predictor with older patients 
reporting higher QOL scores (Hack et al., 2010; Wald et al., 2007; Salonen, Kellokumpu 
Lehtinen, Tarkka, Koivisto, & Kaunonen, 2011). A longitudinal study was conducted to 
evaluate sarcoma patients’ QOL and to explore their demographic and clinical predictors 
of QOL (Paredes, Pereira, Moreira, Simões, & Canavarro, 2011). Researchers used a 
structured questionnaire to collect demographic and clinical data. The sample ages ranged 
from 18-72 years. The majority of patients were exposed to chemotherapy during their 
treatment phase, and 25% were exposed to radiation therapy. Patients scored low QOL at 
baseline and treatment phase, QOL scores in the physical domain at baseline were a 
significant predictor (p = 0.01) for physical functioning at treatment phase while age 
(p = 0.26) marital status (p = 0.09), and professional status (p = 0.55) contributed to a 
significant increase in the total of explained variance. Also there was a significant 
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relationship between symptoms such as pain and fatigue with low financial status at both 
baseline and after treatment.  
Predictors of QOL including patient age, education, place of living, tumor grade 
and impact of initial treatment were studied by Hack and colleagues (2010). , They also 
explored the interaction between predictors of distress and quality of life for cancer 
patients receiving treatment. They reported a significant main effect of chemotherapy on 
patients’ QOL, and age was a significant predictor of emotional wellbeing (p<0.0001). 
Younger women reported worse QOL than older women. The researchers concluded that 
a combination of patient factors such as older age and lack of education or lack of support 
leads patients to withdraw as an adaptation mechanism to stressful situations (Hack et al., 
2010).  
Gender also has been studied in relation to QOL. Females reported worse QOL, 
and a combination of being older women and lack of support and lower education level  
led to lower QOL scores (Hack et al., 2010; Zimmermann et al., 2010). Mystakidou and 
colleagues (2005) evaluated the relationship between psychological morbidity, anxiety 
and depression in 120 patients receiving palliative care.  Strong relationships between 
hospital anxiety and depression and patients’ emotional functioning (p< .0005) were 
found. The influence of gender on physical, emotional, and social functioning and other 
symptoms was high (p<.05) (Mystakidou et al., 2005).  
Contemporary research indicates that patients who are employed report a lower 
risk for undesirable changes in QOL than patients who are retired or unemployed; and 
employed women have a better QOL than unemployed or retired women (Salonen, 
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Kellokumpu Lehtinen, Tarkka, Koivisto, & Kaunonen, 2011; Kandasamy et al 2011). A 
randomized, control trial conducted by Salonen et al. (2011) reported significant 
predictors of patients’ QOL to be: level of education, employment status, having 
children, and exposure to cancer treatments. QOL of both the intervention and control 
groups of patients improved over the six-month after surgery. Body image was 
significantly reduced for both the intervention (p = 0.001) and control groups (p = 0·007). 
Significant systematic adverse effects were noted in the intervention group (p ≤ 0·001) 
and in the control group (p = 0·003).  
Although some have stated that the SF-36 is not a measure of QOL because it 
measures only physical and mental well-being, investigators continue to use it. Using the 
SF-36, employed subjects scored higher on QOL than unemployed or retired subjects.  
Scores for employed subjects ranged around 50 in all scales while they were between 30 
and 40 for the unemployed. QOL scores were lower for subjects who were living alone 
compared to those who are living with families or partners especially for general health 
and social functioning scales of SF-36. (Wald et al., 2007). 
Georges, Onwuteaka-Philipsen, Heide, Wal and Maas. (2005) studied cancer 
patients and their characteristics in their last days in a study designed to assess symptoms 
and symptom management. Results showed a significant increase in symptoms such as 
loss of appetite, feeling unwell, dependency and fatigue. Physicians reported that 
patients’ physical symptoms were managed more than their psychosocial symptoms. The 
number of medical specialties that provide care for dying patients in their last days 
decreased, while other non-medical caregivers increased. The study supported that the 
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participation of family members supported the terminally ill cancer patients and 
facilitated their dying in peace. 
Mental status has been assessed both as cognitive decline and mental well-being 
(Reid-Arndt, Hsieh, & Perry, 2010; Wald et al 2007). Reid et al (2010) assessed the 
effect of delicate cognitive changes on breast cancer patients’ QOL. Demographic 
information, neuropsychological measures, self-reported cognitive difficulties, fatigue 
and social support seeking were predictor variables. The results confirmed how important 
social support was to QOL. Also analysis shown an inverse relationship between self-
reported cognitive complaints and overall QOL (p= 0.08). Psychological morbidity was 
largely predicted by QOL dimensions (p< .05) (Mystakidou et al., 2005). Also 
ssignificant correlations have been found between QOL and physical status (Garrison, 
Overcash, & McMillan, 2011). Although QOL has been studied in different nations, 
research comparing cancer patients from different cultural groups are limited (Wald et al., 
2007).  
Symptom Severity, Distress and Quality of Life 
Researchers indicated that patient symptoms are not being successfully managed, 
Symptom distress in persons with cancer has been shown to have a negative effect on 
overall QOL (McMillan, 2002; Gapstur, 2007). 
Some studies have shown that women report greater symptom distress than men 
(p =0.005) (Zimmermann et al. 2010). Karabulu, Erci, Ozer,  and Ozdemir (2010) 
conducted a cross-sectional study to identify the prevalence and severity of cancer 
patients’ symptoms. In this study 12.5% of patients experienced severe symptoms, while 
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37.5% experienced moderate symptoms. The most frequently reported symptoms among 
a sample of hospice patients with cancer were lack of energy, pain, dry mouth, and 
shortness of breath. The average intensity score was 3.13 (McMillan & Small, 2002). 
To evaluate the incidence and severity of constipation in hospice patients, 
researchers at the University of Texas conducted a large retrospective cohort study in a 
large population-based sample of 50,641 persons who received hospice care. Moderate to 
severe constipation was most dominant among terminally ill cancer patients, mostly 
patients who were diagnosed with respiratory cancers, gastrointestinal or peritoneum 
cancers, and genitourinary organs cancer. Constipation was also highly reported by 
patients with high pain scores or patients on laxatives (Strassels, Maxwell, & Iyer, 2010). 
Researchers conducted a cross-sectional study to evaluate the effect of spiritual 
wellbeing on the rest of QOL dimensions, depression, and symptoms of distress in 
terminally ill cancer patients (Kandasamy, Chaturvedi, & Desai, 2011). The results 
showed that spiritual well-being correlated negatively with mood (r = -0.630, p < 0.001), 
work (r = -0.376, p < 0.001), relationships (r = -0.624, p < 0.001), and enjoyment of life 
(r = -0.681, p < 0.001). Spiritual well-being positively correlated with all the other 
aspects of QOL measures p = 0.008. Patients experiencing stress and anxiety experience 
significantly lower quality of life levels. (Mehnert, Lehmann, Schulte, & Koch, 2007). 
Kirkova et al. (2009) conducted another study to determine the relationship 
between symptom severity and distress from multiple symptoms in cancer, and to 
evaluate the relationship between participants’ demographics and symptom distress. 
Results showed that more than 50% of symptoms reported as distressful, younger patients 
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and females showed higher levels of distress except for anxiety, the primary site group 
does not affect distress, and the prevalence of distress increased with greater symptom 
severity.  
McMillan and Small (2002) evaluated symptom distress and quality of life in 
patients with cancer newly admitted to hospice home care. The results showed that lack 
of energy caused the greatest distress, followed closely by dry mouth and pain. The 
results of the regression analysis indicated constipation intensity was related to QOL at 
the univariate level. When all predictors were considered simultaneously, only the total 
distress score remained a significant predictor of QOL (p < 0.001), accounting for about 
35% of variance. The authors concluded that QOL was affected by symptom distress in 
people with advanced cancer near the end of life. 
To study the incidence and character of problems relating to cancer and treatment 
and their association with symptom distress a group of researchers Recommendations 
were made for health care professionals to consider family caregiver’s assessments of 
patients’ symptom distress when the patient is unable to provide his/her own symptom 
distress self-report. A percentage of 53% of patients reported experiencing emotional 
distress and/or anxiety related to prostate cancer (Mehnert, Lehmann, Schulte, & Koch, 
2007). 
Constipation and Cancer 
Constipation is common in patients with cancer because of their many risk 
factors, and in a cancer patient receiving opiates, constipation is inevitable. 
Unfortunately, this potentially serious problem is often overlooked and under-managed. 
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(McMillan, 2004). It is known that constipation causes symptom distress, and this 
distress affects the QOL of cancer patients and their care givers (Kinzbrunner, Weinreb, 
Policzer 2002; Ferrell, Coyle 2006).  
In a descriptive cross sectional study conducted in palliative care settings in 
Spain, researchers aimed to evaluate the effectiveness of laxative treatment and if there is 
a relationship between constipation and opioids. In this study 91% patients were 
diagnosed with cancer and the constipation prevalence was the highest among them. 
(Noguera, Centeno, Librada, & Nabal, 2010). 
The impact of opioid induced bowel dysfunction in patients treated with opioids 
for pain and were on laxative has been assessed by a multinational survey online 
designed by Bell, Panchal, and Miaskowski (2009). The bowel dysfunction symptoms 
reported in this study by most patients four times a week with a highest severity, and also 
patients stated the impact of bowel dysfunction on their daily life activities and so on 
their quality of life. Around 30% of patients neglected their opioids doses or started 
noncompliance with this treatment in order to have better bowel motility. This study 
supported the idea that the opioid induced bowel dysfunction incidence is high even the 
patients taking laxative and patients experienced new symptoms in addition to 
uncontrolled pain that affects the level of their quality of life.  
 
Constipation and QOL Among Cancer Patients 
 
 
Wald et al. (2007) studied QOL in a multinational survey to compare different 
social and demographic groups with and without constipation and to detect country-
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specific differences among the groups studied, and to assess the impact of constipation on 
quality of life. Health-related QOL (HRQOL) was assessed with the Short Form 36 (SF-
36) questionnaire in 2870 subjects in France, Germany, Italy, UK, South Korea, Brazil 
and USA. Results in all countries showed that QOL scores correlated negatively with 
age, and there were significant differences in HRQOL between constipated and non-
constipated individuals and a significant, negative correlation between the number of 
symptoms and complaints and SF-36 scores. The study showed also a significant 
relationship between constipation and QOL and the influence of social and demographic 
factors on HRQOL in constipated people. 
Chronic constipation will lead to incapacitating symptoms. Health care providers 
usually failed to treat constipation with laxatives, causing negative effects on  the patients 
quality of life (Quigley, Vandeplassche, Kerstens and Ausma, 2009; Outryve, Beyens, 
Kerstens, and Vandeplassche, 2009; Tong, Isenring and Yates, 2009).  
Summary 
The literature showed a significant relationship between constipation and QOL 
and an influence of social and demographic factors on QOL of constipated patients. The 
distress caused by constipation has an impact as well on patients’ QOL. 
Constipation is a serious problem for cancer patients near the end of life, but the 
literature does not address the distress caused by constipation and the effect of this 
distress on hospice patient's quality of life. Thus, there is a need for further clarification 
of constipation and predictors and outcomes connected with it.  
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Chapter Three: Methods 
Research Design 
This chapter presents the methods used in this study. This study was a descriptive, 
correlational design and a secondary analysis of data from an earlier study (McMillan, 
Small, & Haley, 2010). The aim of the original experimental intervention study was to 
evaluate the effectiveness of using standardized assessment tools in order to provide 
systematic feedback from hospice patients and their caregivers. The researchers 
hypothesized that there would be significant differences in hospice outcomes between the 
experimental and the control groups. The researchers used data from 709 cancer patients 
and their caregivers who had been admitted to one of the two large private not-for-profit 
hospices. In both settings the patients received comprehensive services delivered by the 
hospice Interdisciplinary teams. This proposed project is a non-experimental quantitative 
study using previously gathered data to test a new hypothesis with alternative strategies 
to examine relationships not previously analyzed.  
Sample and Setting 
The target population was patients who receive homecare from a large nonprofit 
hospice; the convenience sample was 310 patients. Power analytic techniques indicated 
that with the sample size, with power set at .90 and alpha set at .05, a small to medium 
effect size could be detected. In this study, all patients met the following inclusion 
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criteria; adults diagnosed with cancer who had an identified family caregiver; patients 
who were able to read and understand English, and able to pass mental status screening. 
The setting for the study was two large nonprofit hospices that primarily provide home 
care. The study was approved by the Hospice Bioethics Committees and the University 
Institutional Review Board. 
Instruments 
Five instruments were used in this study to operationalize the variables of interest. 
They were the Memorial Symptom Assessment Scale, the Palliative Performance Scale, 
the Short Portable Mental Status Questionnaire, the Hospice Quality of Life Index, and a 
Patient Demographic Date Form.  
The Memorial Symptom Assessment Scale (MSAS). The MSAS was used to 
measure constipation symptom presence, intensity and distress. Twenty-five symptoms 
are measured, including constipation. Patients mark the form indicating which symptoms 
they are currently experiencing. Item scores for both intensity and distress range from 0 
to 4 with 4 being greater intensity or distress due to constipation. The construct validity 
was evaluated by correlating MSAS scores and quality of lifeQOL. As predicted, there 
was a strong negative correlation (r=-0.72). Coefficient alpha was used to evaluate 
reliability and it was good (r= 0.73-0.74) (McMillan & Small, 2002). 
  The Hospice QOL Index-14 (HQLI-14). is a shortened version of previously 
used and validated 28-item Hospice Quality of Life Index (HQLI). It has 14 items; each 
item is scored on a 0-10 scale; the total score is obtained by adding item scores which 
range from 0-140, while 0 reflects the worst QOL that could be measured and 140 is the 
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best QOL. The factor analysis of the HQLI revealed three factors which 
included: psycho-physiological, functional and social/spiritual wellbeing. Concurrent 
validity was supported by correlation which was analyzed in a hospice sample prior to the 
beginning of the study. Construct validity was evaluated by correlation with the original 
HQLI (r= 0.94, p< 0.001) (Buck, Overcash, & McMillan, 2009). Reliability of the HQLI 
was provided by generation of coefficient alphas for both total scale scores and subscale 
scores, Subscale alphas were .84 and the total alpha when it used with cancer patients 
was (r=.88) (McMillan & Mahon, 1994). 
Palliative Performance Scale (PPS). The PPS was used to measure the 
functional status for patients. The PPS was developed by the Victoria Hospice Society in 
1999. The PPS assesses a patient’s level of ambulation, activity, evidence of disease, self-
care, intake, and consciousness. Patients can score between 0-100%; while 0 means death 
and 100 reflects a person with normal activity level. The PPS scale was designed to 
assess a patient’s functional level and the needs of palliative care patients. Construct 
validity was supported by the strong positive correlation between PPS and Karnofsky 
Functional Status (r= 0.93) (McMillan et al., 2010).Strong correlations were found 
between the scores rated by an oncologist, radiation therapist, and a research assistant 
(r=0.69-0.86). In addition, good reliability as measured by the  alpha coefficient was 
reported (Campos et al., 2009). 
Short Portable Mental Status Questionnaire (SPMSQ). Measures the presence 
of intellectual impairment and the degree of impairment in patients. Scores range from 0 
to 10; a cutoff score of 8 was used in this study. This is a valid instrument to be used for 
detecting moderate to severe cognitive impairment in cancer patients (MacNeil & 
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Lichtenberg, 1999). Evidence was found for the reliability and reliability coefficients 
were greater than 0.80 (Pfeiffer, 1975). 
Demographic Data Form. Included gender, age, race/culture, marital status, 
income, educational level, type of cancer, and physical/mental health status.  
Procedures 
For the parent study, the patients were identified by the research assistants, who 
were nurse data collectors who had been hired for the original study. These research 
assistants visited the homes of patients, consented the patients, and collected baseline 
data (McMillan, Small, & Haley, 2010). 
For this secondary analysis, data was obtained from Dr. McMillan, who gave 
permission for its use. Data was cleaned by reviewing for missing data and by randomly 
selecting cases for double entry. Means of the cases that were double-entered compared 
with the sample means from patients already entered. If differences were found, the 
original data from the paper copies were reviewed to find the errors. These errors were 
corrected. Patients with missing data eliminated from the data set. The revised data set 
used for this proposed secondary analysis.  
Data Analysis 
This study was conducted through secondary analysis of data. First, data was 
analyzed using descriptive statistics, so the frequency, percentage, means and standard 
deviations for quality of life for the overall sample of hospice cancer patients were 
calculated along with all other variables. Correlation coefficients between quality of life 
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and patients' socio-demographic variables and between quality of life and clinical 
characteristics also were calculated.  
Multivariate regression analysis was conducted using QOL as the dependent 
variable, and age, gender, education, functional and mental status, cancer diagnosis, and 
constipation severity as the predictor variables. An exploratory mediation analysis was 
used to assess the mediation effect of the constipation distress. A mediator can be 
explained as a transmitter of the effect of an independent variable (IV) on the dependent 
variable (DV). So the IV affects the DV because the IV affects the mediator, and the 
mediator in sequence affects the DV. (Preacher, Rucker, & Hayes, 2007). Statistical 
significance of the mediated effect can be calculated by dividing the estimate by its 
standard error and comparing the result with the standard normal distribution. For non-
normality of data, both confidence limits for mediated effects and re-sampling methods 
could be used (MacKinnon & Fairchild, 2009). The bootstrapping method was used to 
measure the mediating variable effects because this method has high power and it does 
not make an assumption about normality compared to the Sobel test or Baron and Kenny 
test (Hayes, 2009).  
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Chapter Four: Results 
The purpose of the proposed  study was to determine, using an existing data set, 
predictors of QOL and to evaluate the mediating effect of constipation distress in patients 
who receive homecare from a large nonprofit hospice. This chapter includes three 
sections; the first section represents description for demographic variables and clinical 
characteristics regarding cancer diagnosis, constipation severity and intensity, and 
patient’s physical and mental health. In the second section, correlations between the 
predictors of QOL and the overall QOL; and the third section represent the mediation 
analysis. 
Sample   
The sample consisted of 310 patients; the majority of whom were white (96.9%) 
(Table 1). The sample had slightly more males (55.3%) than females. Patients in this 
sample tended to be married (63.6%), and the majority of patients in this sample were 
living with someone (93.4%). The patients’ ages ranged between 21 and 95 years old, 
with a mean age of 72.7 years (SD= 12.1). Only 4.1 % of the patients in the sample were 
under 50 years old, and more than half of this sample were 70 years and older.  The level 
of education among these patients was assessed by asking about the number of years of 
education. The mean was 12.7 years of education (SD= 2.9) (Table 2). The most common 
site for primary cancer was the lung (34%) (Table 1).  
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Table 1. Frequency and Percent of Patients by Demographic Variables 
Variable Frequency Percent 
Gender   
   Male 171 55.3 
   Female 138 44.7 
Marital Status   
   Currently married 203 63.6 
   Not-married 107 18.5 
Ethnicity   
   White 299 96.9 
   Other 11 0.4 
Cancer Diagnosis   
   Lung 105 34.0 
   GI/Colorectal 79 25.6 
   Genitourinary 33 10.9 
   Breast 16 5.6 
   Gynecological 15 5.2 
   Other 62 18.6 
Reported Constipation 310 44.5 
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Table 2. Means and Standard Deviations of Patients’ Age, Education, PPS Scores, 
Constipation Severity Scores and Constipation Distress Scores 
Variable Mean Standard Deviation 
Age 72.7 12.1 
Years of Education 12.7 2.9 
Physical Function (PPS)  57.1 10.9 
Mental Status (SPMSQ) 9.23 0.9 
Constipation Severity 2.44 1.1 
Constipation Distress 2.47 1.3 
QOL Scores 102.2 17.4 
 
Descriptive Statistics 
Constipation was present among 44.5% of the patients in the sample (Table 1). 
According to the sample, the mean for constipation severity was 2.44 (SD= 1.1), and the 
mean for constipation distress was 2.47 (SD= 1.3). PPS was used to evaluate patients’ 
physical health. The mean score was 57.1 (SD= 10.9), while the SPMSQ was used for 
patients’ mental health evaluation, and yielded a mean score of 9.23 (SD= 0.9). Mean 
quality of life was 102.7 (SD=17.4) (Table 2). 
Correlations   
Bivariate correlations were calculated between QOL total scores and the target 
variables Weak significant correlations were found between QOL and patients’ age and 
education. Weak but significant correlations were found between PPS and SPMSQ, and 
between years of education and SPMSQ. There was also a significant negative 
correlation between constipation severity and QOL total (p=0.01), and another significant 
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correlation of 0.25 between constipation distress and QOL total (p=0.01). Finally, there 
was a significant strong correlation of 0.69 between constipation severity and 
constipation distress (p=0.01).  
Predictors 
A regression analysis using bootstrapping method was done to answer question 
number one: Do socio-demographic variables age, gender, marital status, race/culture, 
education, and socioeconomic status), clinical characteristics (type of cancer, physical 
and mental status) and constipation intensity predict quality of life in hospice patients 
with cancer? The results showed that age, ethnicity, constipation severity and functional 
status were significant predictors for QOL (P<0.05) (Table 4). 
Mediation  
The bootstrapping method was used to measure the mediating variable effects and 
significance. The bootstrapping analysis revealed direct, partial and total effects with 
standard errors and significance. This analysis was done to answer question number two: 
To what extent does constipation distress serve as a mediator in the relationship between 
constipation intensity and overall quality of life in hospice patients with cancer? Results 
are presented in Table 4. 
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Table 3: Pearson Correlation Coefficients between the Predictors and the QOL. 
 PSMSQ Patients 
Age 
PPS 
Total 
Years of 
education 
Constip. 
Severity 
Constip.
Distress 
QOL 
 
PSMSQ 
r 
n 
 
-0.11c 
(307) 
0.24c 
(309) 
0.19c 
(308) 
-0.10 
(310) 
-0.03 
(310) 
-0.02 
(302) 
Patients Age 
r 
n 
  
 
-0.09b 
(306) 
 
-0.06 
(305) 
-0.08 
(308) 
-0.07 
(308) 
 
0.18 c 
(299) 
PPS Total 
r 
n 
 
 
 
-0.04 
(704) 
-0.11 
(310) 
-0.02 
(310) 
 
0.18 c 
(301) 
Years of 
education 
r 
n   
  
 
 
 
0.03 
(309) 
 
 
 
0.06   
(309) 
 
 
 
-0.12 c 
(300) 
Constipation 
Severity 
r 
n 
 
 
  
 
0.69c 
(311) 
-0.24c 
(302) 
Constipation 
Distress 
r 
n 
 
 
    
-0.25c 
(302) 
QOL 
r 
n 
       
 a
 
P< 0.05  
b P<0.01 
A significant relationship between the dependent variable, QOL, and the 
independent variable, constipation severity, was found (p<0.05). Both, the direct effect of 
the independent variable on the mediator, constipation distress, as well as the direct effect 
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of the mediator on the dependent variable, were significant (p<0.05). However, the direct 
path between the independent variable and dependent variable with the mediator was not 
significant (p=0.24), which, according to Baron and Kenny, indicates that constipation 
distress mediates the effect of constipation severity on the QOL (Baron & Kenny, 1986) 
(Table 3). 
Table 4: Direct, Partial, and Total Effects of Bootstrapping Mediation Analysis. 
 
Unstandardized 
Coefficient 
N= 296  
       Standard 
error 
P 
Effect    
   Effect of IV on mediators         0.79 0.05 0.00 
   Direct effect of  mediator 
      on DV 
-1.98 0.99 0.04 
   Total effect of IV on DV -2.91 0.85 0.00 
   Direct effect of IV on DV  -1.35  1.15  0.24  
QOL Predictors    
   Age 0.23 0.08 0.00 
   Gender -0.14 1.90 0.94 
   Education -0.52 0.31 0.09 
   PPS total 0.19 0.09 0.04 
   SPMSQ 0.99 1.06 0.36 
   Ethnicity -11.44 5.34 0.03 
   Cancer Diagnosis   -0.71  1.99 0.72  
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Bootstrapping analysis revealed a significant effect of the following control 
variables (covariates) on the QOL: age, PPS score, and ethnicity; all of these variables 
were significant at less than 0.05 levels. On the other hand, gender, education, SPMSQ, 
living arrangement, and type of cancer were not significant.  
In this analysis, constipation distress was proposed as a mediator between 
constipation severity and QOL. The number of bootstrap resamples was 5000. The bias-
corrected confidence interval on the 95% level of confidence showed that constipation 
distress had a mediation effect on the relationship between constipation severity and 
QOL. (Table 3) 
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Chapter Five: Discussion, Conclusions, and Recommendations  
Discussion 
The purpose of this study was to determine, using an existing data set, predictors 
of QOL and to evaluate the mediating effect of constipation distress in patients who 
receive homecare from a large non-profit hospice. This study was designed to address the 
following questions: To what extent does constipation distress serve as a mediator in the 
relationship between constipation intensity and overall quality of life in hospice patients 
with cancer?  
Patients with cancer often experience constipation which may be a result of the 
cancer, low fiber diet, lack of activity or opioids (McMillan, 2004). In this study, both 
severity and distress from constipation were evaluated. The characteristic of symptom 
distress is known as the degree of discomfort associated with a symptom experienced by 
the patient (Sarna, Lindsey, Brecht, Dean, & McCorkle, 1994). Analyzing all symptom 
dimensions reflects the patient's interpretation of a symptom (Molassiotis, Wengstrom, & 
Kearney, 2010) 
Constipation is common in patients with cancer because of their many risk 
factors, and in a cancer patient receiving opiates, constipation is inevitable. 
Unfortunately, this potentially serious problem is often overlooked and under-managed. 
(McMillan, 2004). In this study 44.5% of the patients reported having constipation, and 
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more than 70% of patients with constipation described the severity as 2 or more on a 
scale from 0-4. This moderate to severe level of constipation was also dominant in a 
study conducted with a large hospice population of 50,641 patients (Strassels et al, 2010). 
The literature supported that distress has an impact on the people with advanced 
cancer near the end of life QOL (McMillan & Small 2002). The patients on the study 
were asked about how much distress they had because of constipation; 92.6% had 
reported a level of distress that ranged from one to four with a 2.47 mean on a scale from 
0-4. The level of distress in this study was congruent with the literature which showed a 
percentage of 50%-53% of patients experienced distress caused by their symptoms 
(Kirkova et al, 2007, Mehnert et al 2007). This means that both, the symptom intensity 
and distress as well as the relationship between constipation and quality of life need to be 
considered when nurses manage patients to achieve the best symptom management for 
cancer patients. A limitation for the study is that the constipation variables were asked 
and evaluated on a single scale from 0 to 4; this single item scale may not reflect all the 
clinically important signs and symptoms of constipation. 
The study included 310 cancer patients near the end of life; however, less than 
half reported constipation on the MSAS leaving a sample of 310 for the mediation 
analysis. The sample had a wide range of different age groups, ranging between 21 and 
95 years old, and the mean age was 72.7 years. Although there was a wide range of ages, 
only 4.1 % of the patients in the sample were under 50 years old, and more than half of 
this sample were 70 years and older. The fact that the majority of patients in this study 
were over 70 years old may affect the generalizability of the study to all cancer patients. 
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Patients within this sample came from different ethnic backgrounds, including 
African-American, Hispanic, Asian-Pacific Islander, and white. However, the great 
majority of the patients (97%) were white. Thus, results are not generalizable to all 
cancer patients because cancer affects people of all races and ethnicities. This result 
probably occurred because relatively small numbers of minority cancer patients seek 
hospice services.  Future studies should attempt to include larger numbers of minority 
patients. The majority of patients were living with someone and not alone. This finding 
was the result of the way in which patients were identified in the original study; all 
patients had to have a family caregiver. Thus, these results are not generalizable to 
patients who do not have family caregivers, who are receiving hospice care in nursing 
homes or assisted living facilities, or who are residing in a hospice house. The patients 
reported a fairly high level of quality of life (mean = 102.2; SD=17.4), which represents 
73% of the highest score of 140. This score is similar to the mean of another group of 255 
hospice patients with cancer studied earlier (McMillan & Weitzner, 1998).  
The study yielded that age has a significant negative relationship with QOL 
(P<0.05) and this was supported by previous research (Hack et al., 2010). Age and 
ethnicity were significant predictors that correlated with the cancer patients’ QOL.  
The SPMSQ was used as a screening instrument for cognitive impairment, and as 
a result the patients in the study had relatively high cognitive function; that is, patients 
with lower mental status were screened out of the study. This restricted range problem 
may explain why this relationship between mental health and QOL was not significant 
while the literature supported the influence of the patients’ mental health on their overall 
QOL (Kandasamy, 2011).  
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In this study the patients’ mean score for their physical status was 57.1 
(SD=10.9), which means that they were fully conscious, but they needed occasional 
assistance with self-care, and their significant disease reduced their ambulation and 
activity level. Again, this variable had a restricted range because patients with scores 
below 40 were excluded from the study. Never-the-less, patients’ physical status 
correlated positively with their QOL (P<0.01) as might be expected.  
The more severe constipation became the lower were the QOL scores reported; 
this seems like a reasonable finding; that is, it should be expected that as a symptom 
increases in intensity, the distress also would increase and would have a negative effect 
on the QOL. The strongest correlation in this study was found between constipation 
severity and constipation distress 0.69 (P<0.01), in an earlier study the researcher 
concluded that constipation distress increased with increasing its severity, and 69% of 
patients with constipation complained from high level of constipation distress (Kirkova et 
al, 2006). 
In order to evaluate the mediation effect of constipation distress between the 
predictor variables and QOL, a bootstrapping mediation analysis was used rather than  
both Baron and Kenny’s or Sobel’s approach. An extra analysis done based on Baron and 
Kenny reflected a significant direct path between the constipation severity and QOL 
(P=0.00) and a trend of mediation effect on the direct path with the constipation distress 
as a mediator. The benefits of bootstrapping methods are the higher power and that 
bootstrapping does not make an assumption about normality. The patients’ age, gender, 
education, physical and mental health, ethnicity and type of cancer were covariates 
controlled for in the regression analysis.  
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The mediation effect was significant when the level of confidence for confidence 
intervals was 95% and number of bootstrap resamples was 5000. With this new 
information that constipation distress mediates the relationship between constipation 
intensity and QOL, nursing has additional evidence of the importance of symptom 
distress. Thus, nurses should assess constipation intensity but also should determine the 
extent to which it is distressing to the patient. If this is the case for constipation, it may 
also be true for other symptoms. 
Conclusions and Recommendations  
Cancer patients suffer from many symptoms that could be related to the cancer 
itself or the cancer treatments. The symptom intensity and distress as well as the 
relationship between constipation and quality of life need to be seen in a holistic 
approach to achieve the best symptom management for cancer patients. Oncology nurses 
should consider the predictors of the patients’ QOL in order to identify patients who may 
be at risk for poor future QOL. 
Committed individuals have already conducted some important research in 
symptom management and end of life care for cancer patients (McMillan et al, 2010), but 
the relationships between the symptom and their effect on patients and also between all 
symptoms need to be addressed more in the literature. The sample as mentioned before 
was mostly white, alert and functioning, and further biased by having family around 
them. Further studies should be conducted to learn about patients who are from minority 
groups, are not mentally or functionally capable and who have less available support 
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systems.  In addition, developing better tools for assessing the symptom experience may 
help in improving symptom distress management and alleviating patients suffering.  
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